IP Library Granted Patent US 11,229,500
Granted Patent B2
US 11,229,500 · App. 16/453,932 · Granted Jan 25, 2022

Directional stimulation leads and methods

Inventors: Rick Sanghera (San Clemente, CA); Alan Marcovecchio (San Clemente, CA); Sean P. McGeehan (Encinitas, CA)
Assignee: ATACOR MEDICAL, INC.
A61B90/39A61B90/02A61N1/0504A61N1/0563A61N1/0587A61N1/362A61N1/3621A61N1/36521A61N1/36542A61N1/36557A61N1/3787A61N1/37217A61N1/37264A61N1/3956A61B2090/3966A61B2090/3983A61N1/059A61N1/3752
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,229,500
App. No.
16/453,932
Granted
Jan 25, 2022
Kind
B2
Abstract

Systems, methods and devices for delivering stimulating energy with a lead having a directional electrode are disclosed. The lead includes a directional electrode having an electrically active portion configured to emanate stimulating energy from an exposed portion of the directional electrode. The lead also has an electrically insulating portion around at least part of the circumference of the lead. The electrically insulating portion is configured to insulate surrounding muscle and/or tissue from the stimulating energy when the lead is implanted in the patient.

Claims (25)

1. A lead for implantation in a patient, the lead comprising:

a directional electrode configured for implantation on or near the inner surface of a rib or the inner surface of the innermost intercostal muscle and not physically in contact with the heart or the pericardium of the heart, the directional electrode having an electrically active portion configured to emanate stimulating energy from an exposed portion of the directional electrode toward the pericardium and the heart; and

an electrically insulating portion around at least part of a circumference of the lead, the electrically insulating portion configured to insulate surrounding muscle and/or tissue from the stimulating energy when the lead is implanted in the patient.

2. The lead of claim 1 , wherein the electrically insulating portion surrounds the entire circumference of the lead but leaves exposed a distal tip of the lead so that the directional electrode is at the distal tip of the lead.

3. The lead of claim 1 , wherein the directional electrode is electrically insulated on all sides other than one exposed side.

4. The lead of claim 1 , wherein the directional electrode is located away from a distal tip of the lead.

5. The lead of claim 4 , wherein the directional electrode is electrically insulated over a significant portion of the lead's circumference.

6. The lead of claim 4 , wherein, at the location of the directional electrode, approximately 50% of the circumference of the lead is electrically insulating, leaving approximately 50% of the circumference of the lead exposed.

7. The lead of claim 4 , wherein, at the location of the directional electrode, approximately 75% of the circumference of the lead is electrically insulating, leaving approximately 25% of the circumference of the lead exposed.

8. A method of implanting a lead in a patient, the lead having a directional electrode and an electrically insulating portion around at least part of a circumference of the lead, the directional electrode having an electrically active portion configured to emanate stimulating energy from an exposed portion of the directional electrode, the method comprising:

placing the lead in the patient such that the electrically insulating portion of the lead is on or near an inner surface of a rib or an inner surface of the innermost intercostal muscle of the patient and not physically in contact with the heart or the pericardium of the heart where the electrically insulating portion insulates the intercostal muscle from the stimulating energy; and

directing the directional electrode of the lead toward a heart of the patient.

9. The method of claim 8 , wherein placing the lead in the patient further comprises implanting the lead through an intercostal space of the patient in a region of a cardiac notch.

10. The method of claim 8 , wherein the placing of the lead results in the electrically insulating portion touching the intercostal muscle.

11. The method of claim 8 , wherein placing the lead further includes the lead being proximate the heart, but not being physically in contact with the heart or a pericardium of the heart.

12. A cardiac pacing system comprising:

a lead implanted in a patient through an intercostal space and on or near an inner surface of a rib or an inner surface of an innermost intercostal muscle in a region of a cardiac notch of the patient and not physically in contact with the heart or the pericardium of the heart, the lead comprising:

a directional electrode having an electrically active portion configured to emanate stimulating energy from an exposed portion of the directional electrode toward the pericardium and the heart; and

an electrically insulating portion around at least part of a circumference of the lead, the lead implanted such that the electrically insulating portion insulates surrounding muscle and/or tissue from the stimulating energy.

13. The cardiac pacing system of claim 12 , wherein the electrically insulating portion surrounds the entire circumference of the lead but leaves exposed a distal tip of the lead so that the directional electrode is at the distal tip of the lead.

14. The cardiac pacing system of claim 12 , wherein the directional electrode is electrically insulated on all sides other than one exposed side.

15. The cardiac pacing system of claim 12 , wherein the directional electrode is located away from a distal tip of the lead.

16. The cardiac pacing system of claim 15 , wherein the directional electrode is electrically insulated over a significant portion of the lead's circumference.

17. The cardiac pacing system of claim 15 , wherein, at the location of the directional electrode, approximately 50% of the circumference of the lead is electrically insulating, leaving approximately 50% of the circumference of the lead exposed.

18. The cardiac pacing system of claim 15 , wherein, at the location of the directional electrode, approximately 75% of the circumference of the lead is electrically insulating, leaving approximately 25% of the circumference of the lead exposed.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 26, 2019
From: SANGHERA, RICK; MARCOVECCHIO, ALAN; MCGEEHAN, SEAN P.
To: ATACOR MEDICAL, INC.
Reel/Frame 051122/0594 →
Continuity (7)
Continuation 15644714 · Jul 7, 2017
Continuation In Part 14846578 · Sep 4, 2015
Provisional Application 62360110 · Jul 8, 2016
Provisional Application 62083516 · Nov 24, 2014
Provisional Application 62146569 · Apr 13, 2015
Provisional Application 62045683 · Sep 4, 2014
Related Publication 20190336241A1 · Nov 7, 2019